Literature DB >> 29273329

Validation of the Friedewald formula for the estimation of low density lipoprotein cholesterol in a sub-Saharan African population.

Simeon-Pierre Choukem1, Tasha Manases2, Jean-Pierre Nda-Mefoo3, Christian Akem Dimala4, Yannick Mboue-Djieka5, Eugene Sobngwi6, Andre-Pascal Kengne7.   

Abstract

BACKGROUND: Low density lipoprotein cholesterol (LDL-C) levels are used to estimate cardiovascular disease (CVD) risk and to guide prescriptions. To circumvent the challenges of direct LDL-C measurement, guidelines recommend the use of Friedewald formula derived LDL-C levels. Despite reported limitations of this formula, its validity in sub-Saharan Africans has not been adequately investigated.
OBJECTIVE: To assess the validity of the Friedewald formula derived against directly (homogeneous) measured LDL-C in adult Cameroonians.
METHODS: We reviewed the fasting lipid profiles of 2500 patients, performed between March 2012 and January 2016 using enzymatic colorimetric method (reference), at the Douala General Hospital laboratory. The Friedewald formula was used to calculate LDL-C from total cholesterol, high density lipoprotein cholesterol and triglyceride levels. Calculated LDL-C values were compared to the reference values, and clinical significance of differences between the two methods was assessed using total error allowable (TEa).
RESULTS: The difference between means of calculated and the reference LDL-C values was neither statistically nor clinically significant (3.33±1.51 vs. 3.33±1.25mmol/l; p=0.704). The calculated LDL-C correlated positively with the measured LDL-C value (r=0.749) and both methods showed a good agreement on Bland-Altman plot. Conversely, there was only moderate agreement (kappa=0.478, 95% CI: 0.455-0.502) between the two values in the stratification of cardiovascular risk according to the National Cholesterol Education Program/Adult Treatment Panel III. Consequently, 40.6% of the participants were misclassified.
CONCLUSION: Friedewald formula is technically accurate but has a modest clinical accuracy which can translate into a substantial misclassification of patients' cardiovascular risk and subsequent inappropriate therapeutic decisions.
Copyright © 2017 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Agreement; Cameroon; Cardiovascular risk; Direct homogenous assay; Friedewald formula; Low density lipoprotein cholesterol; Sub-Saharan Africa

Mesh:

Substances:

Year:  2017        PMID: 29273329     DOI: 10.1016/j.clinbiochem.2017.12.008

Source DB:  PubMed          Journal:  Clin Biochem        ISSN: 0009-9120            Impact factor:   3.281


  4 in total

1.  High-Density Lipoprotein Cholesterol and the Risk of First Ischemic Stroke in a Chinese Hypertensive Population.

Authors:  Yue Zhang; Jingyi Li; Chengzhang Liu; Hongxiang Yu; Chen Chen; Chonglei Bi; Chongqian Fang; Hai Ma; Aimin Li; Qing Dong; Lishun Liu; Binyan Wang; Xiao Huang; Xiaoshu Cheng; Pierre Zalloua; Xiping Xu; Yong Huo; Gang Li
Journal:  Clin Interv Aging       Date:  2021-05-14       Impact factor: 4.458

2.  Clinical Validation of Eleven Formulas for Calculating LDL-C in Iran.

Authors:  Fereshteh Atabi; Reza Mohammadi
Journal:  Iran J Pathol       Date:  2020-07-18

3.  Lipoprotein-Associated Phospholipase A2 is Linked with Poor Cardio-Metabolic Profile in Patients with Ischemic Stroke: A Study of Effects of Statins.

Authors:  Hayder M Alkuraishy; Ali I Al-Gareeb; Huda J Waheed
Journal:  J Neurosci Rural Pract       Date:  2018 Oct-Dec

4.  Predictors of the Prevalence of Dyslipidemia and Influencing Factors for Young Health Examination Cohort: A Cross-Sectional Survey.

Authors:  Hui Zhang; William Robert Kwapong; Meng-Meng Shao; Jue-Yue Yan; Xian-Da Lin; Bo-Bei Chen; Ke-Yang Chen
Journal:  Front Public Health       Date:  2020-09-23
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.